Search
Search Results
-
HEMOLYTIC DISEASES AND RHESUS IMMUNIZATION: MODERN SCIENTIFIC APPROACHES AND CHALLENGES
In our country, the number of pregnant women with Rh-sensitization remains stable every year, showing no tendency to decrease. The main reason for this is the insufficient implementation of prophylaxis after pregnancy termination (such as spontaneous abortion, ectopic pregnancy, or the birth of a Rh-positive baby), specifically due to the failure to administer anti-Rh(D) immunoglobulin. Previously effective methods, such as antigen desensitization, plasmapheresis, hemosorption, and intravenous administration of immunoglobulins, are now considered historical and are no longer widely used in practice. This article presents an in-depth review and analysis of the literature from both foreign and local authors on the diagnosis of hemolytic disease of the fetus and non-invasive prevention of Rh-immunization. It covers the pathogenesis of hemolytic diseases, modern diagnostic methods, immunological foundations, and therapeutic approaches, as well as the prevention of Rh-immunization and advanced international practices. The paper also discusses new clinical protocols and innovative technologies aimed at protecting the fetus, based on the most recent medical guidelines and approaches.